Low-dose of relaxin protects against arrhythmias and adverse left ventricle remodeling

Int J Cardiol. 2018 Jan 1:250:60-61. doi: 10.1016/j.ijcard.2017.10.028.

Authors

Attila Kiss¹, Bruno K Podesser²

Affiliations

¹ Ludwig Boltzmann Cluster for Cardiovascular Research at the Center for Biomedical Research, Medical University of Vienna, Vienna, Austria. Electronic address: attila.kiss@meduniwien.ac.at.
² Ludwig Boltzmann Cluster for Cardiovascular Research at the Center for Biomedical Research, Medical University of Vienna, Vienna, Austria. Electronic address: bruno.podesser@meduniwien.ac.at.

PMID: 29169762
DOI: 10.1016/j.ijcard.2017.10.028

No abstract available

Publication types

Editorial
Comment

MeSH terms

Arrhythmias, Cardiac
Humans
Relaxin*
Ventricular Remodeling*

Substances

Relaxin